Hematopoietic Biorepository and Cellular Therapy Core

Overview of Services

The Hematopoietic Biorepository and Cellular Therapy Core provides resources and services related to the procurement, processing, production, storage, banking, analysis and distribution of cells derived from human blood, bone marrow, and umbilical cords. The Cellular Therapy component supports clinical grade cell manufacturing for Phase 1 and 2 cell and regenerative medicine clincial trials.

The Mission of the Core

Enable access to annotated clinical blood and bone marrow samples to support basic and translational research. An active IRB is maintained to consent and procure blood and bone marrow samples and related case data from cancer patients and healthy donors for distribution to Case CCC investigators. 

Assist users with specialized hematopoietic cell assays. Guidance and services are provided to enable investigators to perform specialized hematopoietic cell assays such as colony assays.

Support the development and implementation of cellular therapy clinical trials. Support is provided in all aspects of clinical cell therapy, from assisting with regulatory approval to oversight and manufacture of clinical grade cells.

Hours of Operation and Location 

Links and Resources

1. HBCT website